ADMA Biologics Inc (ADMA)
20.20
-1.27
(-5.92%)
USD |
NASDAQ |
Nov 14, 16:00
20.17
-0.03
(-0.15%)
After-Hours: 20:00
ADMA Biologics Gross Profit (Annual): 88.94M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 88.94M |
| December 31, 2022 | 35.26M |
| December 31, 2021 | 1.173M |
| December 31, 2020 | -19.07M |
| December 31, 2019 | -10.16M |
| December 31, 2018 | -25.21M |
| December 31, 2017 | -6.404M |
| Date | Value |
|---|---|
| December 31, 2016 | 4.300M |
| December 31, 2015 | 2.866M |
| December 31, 2014 | 2.173M |
| December 31, 2013 | 1.044M |
| December 31, 2012 | 0.4491M |
| June 30, 2011 | 0.00 |
| June 30, 2010 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
-19.07M
Minimum
2020
88.94M
Maximum
2023
19.23M
Average
1.173M
Median
2021
Gross Profit (Annual) Benchmarks
| Corcept Therapeutics Inc | 475.89M |
| Madrigal Pharmaceuticals Inc | -- |
| Assembly Biosciences Inc | -- |
| TG Therapeutics Inc | 219.53M |
| Krystal Biotech Inc | 47.60M |